We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.97%
AUM
$300M
AUM Growth
+$81.3M
Cap. Flow
+$53.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
30.67%
Holding
195
New
35
Increased
77
Reduced
34
Closed
15

Top Buys

Rank Stock Value
1
ARKG icon
ARK Genomic Revolution ETF
ARKG
+$7.21M
2
TME icon
Tencent Music
TME
+$6.16M
3
MMYT icon
MakeMyTrip
MMYT
+$5.61M
4
ZTO icon
ZTO Express
ZTO
+$5.17M
5
HCAT icon
Health Catalyst
HCAT
+$3.76M

Sector Composition

Rank Sector Weight
1 Technology 20.52%
2 Miscellaneous 17.57%
3 Consumer Discretionary 15.83%
4 Healthcare 12.25%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$15.9M 5.31%
120,075
+25,474
+27% +$3.06M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.24T
$10.6M 3.54%
121,240
+2,360
+2% +$199K
BABA icon
3
Alibaba
BABA
$296B
$9.93M 3.31%
42,657
+1,570
+4% +$436K
AMZN icon
4
Amazon
AMZN
$2.87T
$9.35M 3.12%
57,420
+1,000
+2% +$160K
ARKG icon
5
ARK Genomic Revolution ETF
ARKG
$1.88B
$8.44M 2.82%
+90,517
New +$7.21M
MSFT icon
6
Microsoft
MSFT
$3.81T
$7.85M 2.62%
35,279
+4,634
+15% +$996K
SBUX icon
7
Starbucks
SBUX
$123B
$7.73M 2.58%
72,262
+1,327
+2% +$127K
KO icon
8
Coca-Cola
KO
$386B
$7.52M 2.51%
137,099
-7,115
-5% -$368K
TME icon
9
Tencent Music
TME
$14B
$7.3M 2.43%
+379,223
New +$6.16M
MMYT icon
10
MakeMyTrip
MMYT
$5.55B
$7.29M 2.43%
+246,992
New +$5.61M
HYS icon
11
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
$6.81M 2.27%
69,341
+25,337
+58% +$2.43M
ABBV icon
12
AbbVie
ABBV
$451B
$6.79M 2.27%
63,410
+3,473
+6% +$334K
PRAH
13
DELISTED
PRA Health Sciences, Inc.
PRAH
$6.73M 2.24%
53,662
+4,989
+10% +$558K
CSCO icon
14
Cisco
CSCO
$433B
$6.59M 2.2%
147,209
+14,142
+11% +$581K
FISV
15
Fiserv Inc
FISV
$28.3B
$6.36M 2.12%
55,888
+5,290
+10% +$570K
ZTO icon
16
ZTO Express
ZTO
$16.3B
$5.93M 1.98%
203,336
+176,049
+645% +$5.17M
LOGI icon
17
Logitech
LOGI
$14B
$5.58M 1.86%
61,472
-4,664
-7% -$403K
WMT icon
18
Walmart Inc
WMT
$820B
$5.41M 1.8%
112,614
+6,063
+6% +$294K
FAST icon
19
Fastenal
FAST
$57.1B
$5.4M 1.8%
221,196
+5,808
+3% +$137K
IGSB icon
20
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$5.01M 1.67%
90,797
+44,418
+96% +$2.44M
ICE icon
21
Intercontinental Exchange
ICE
$91.1B
$4.65M 1.55%
40,342
+4,460
+12% +$463K
HCAT icon
22
Health Catalyst
HCAT
$120M
$4.44M 1.48%
+101,938
New +$3.76M
GLD icon
23
SPDR Gold Trust
GLD
$149B
$4.2M 1.4%
23,572
-7,370
-24% -$1.3M
PG icon
24
Procter & Gamble
PG
$334B
$4.18M 1.39%
30,012
+4,288
+17% +$599K
COO icon
25
Cooper Companies
COO
$13.9B
$3.99M 1.33%
43,968
+428
+1% +$36.7K

Similar funds

Bellecapital's Q4 2020 Portfolio in Review

As of Q4 2020, Bellecapital held 195 positions worth $300M, up 37% from $219M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellecapital deployed $53.7M of net new capital in Q4 2020, opening 35 new positions and adding to 77 existing holdings. Its largest new stake was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $1.3M trimmed.

  • Bellecapital's largest Q4 2020 buy was ARK Genomic Revolution ETF: 90,517 shares worth $8.44M.
  • Bellecapital added most to ZTO Express in Q4 2020, an estimated $5.17M increase.
  • Bellecapital's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $1.3M.
  • Bellecapital fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $5.96M.
  • Bellecapital's ten largest holdings make up 31% of its $300M portfolio in Q4 2020.
  • Bellecapital opened 35 new positions and closed 15 in Q4 2020.
  • Bellecapital's portfolio value rose 37% quarter-over-quarter to $300M.

Based on Bellecapital's 13F filing for Q4 2020, filed 14 Jan 2021.